AstraZeneca Says It Will Start Benefiting From Its Vaccine

Pharmaceutical maker AstraZeneca is selling its coronavirus vaccine at nonprofit prices as part of a promise to bring the vaccine to market at a cost during the pandemic. But on Friday, the Anglo-Swiss company, reporting third quarter earnings He said he would begin pricing his vaccine to make a “modest” profit as “new orders are …